Novogen (NVGN) Stock Falls Today on Private Placement

NEW YORK (TheStreet) -- Shares of Novogen  (NVGN) fell 16.79% to $7.68 in late morning trading Monday after the Australian and U.S. biotechnology company announced it had conducted a private placement and offered rights to shareholders.

The company announced late Monday that it agreed to issue approximately 51 million fully-paid ordinary shares plus one attaching 6-month option and half of one attaching 5-year option for every ordinary share issued to institutional investors in the U.S. in a private placement.

The company expects aggregate gross proceeds of approximately AU$15.5 million from the placement, which is expects to close on or about April 24. 

Novogen will also undertake a 1-for-6 non-renounceable rights issue offering of fully-paid ordinary shares to raise up to a maximum of approximately AU$15 million.

More than 2 million shares had changed hands as of 11:50 a.m., compared to the daily average volume of 1,133,600.

NVGN ChartNVGN data by YCharts

More from Markets

Your Need to Know - Forward Look

Your Need to Know - Forward Look

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

How to Be a Tactical Investor in the Current Market

How to Be a Tactical Investor in the Current Market

How E-Mini S&P 500 Revolutionized Equity, Electronic Trading

How E-Mini S&P 500 Revolutionized Equity, Electronic Trading

Dow Gains, S&P 500 and Nasdaq Slip; Ford Hits 52-Week Low

Dow Gains, S&P 500 and Nasdaq Slip; Ford Hits 52-Week Low